Last updated on December 2019

A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma

Brief description of study

This study is evaluating the efficacy of acalabrutinib in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma.

Clinical Study Identifier: NCT02972840

Find a site near you

Start Over

Research Site

Rennes Cedex, France
  Connect »